Coming up short
Shortages of drugs for treating cancer and other diseases are affecting patient care, but what is being done to stop this serious problem, asks Susan Mitchell.
In early February, concerns began to mount in the United States over a shortage of a drug used to treat cancers including childhood leukaemia, bone cancer and osteosarcoma.
The shortage of the drug - known as preservative-free methotrexate - was caused by manufacturing problems at one of the few plants in the US which make it. The manufacturer had suspended supplies because of production and quality concern, and stocks subsequently dwindled to the point that...
Subscribe from just €1 for the first month!
All Digital Access + eReader
Unlimited Access for 1 Month
*New subscribers only
€149 For the 1st Year
Unlimited Access for 1 Year
90 Day Pass
Unlimited Access for 2 Years
Get a Business Account for you and your team